Disease-specific Resource Utilization
Disease-Specific Resource Utilization is a metric that quantifies the consumption of healthcare resources uniquely attributable to the diagnosis, treatment, and management of a particular disease, distinguishing it from general or nonspecific healthcare utilization patterns.
88
Publications
7K
Citations
499
Authors
311
Institutions
Publications per year
2017–2026
24
88
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Ezekiel Emanuel, Govind Persad, Ross Upshur et al. · New England Journal of Medicine · 2020 · 3.2K citations
Bilateral Vestibular Deficiency
Daniel Q. Sun, Bryan K. Ward, Yevgeniy R. Semenov et al. · JAMA Otolaryngology–Head & Neck Surgery · 2014 · 147 citations
Shanthi Mendis, Igbal Al Bashir, Lanka Dissanayake et al. · International Journal of Hypertension · 2012 · 146 citations · Full text
Public Affairs, Chronic Disease Control, Chronic Disease Prevention +17
1–5 of 88
499
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 499
311
Harvard University
Cambridge, United States
6 h-index
15 publications
618 citations
Optum (United States)
Eden Prairie, United States
4 h-index
8 publications
446 citations

Research Triangle Park Foundation
Durham, United States
4 h-index
5 publications
510 citations
Université Paris Cité
Paris, France
3 h-index
7 publications
138 citations

Karolinska Institutet
Stockholm, Sweden
3 h-index
5 publications
245 citations
Pfizer (United States)
New York, United States
3 h-index
7 publications
168 citations
Novartis (Switzerland)
Basel, Switzerland
3 h-index
4 publications
197 citations

Johns Hopkins University
Baltimore, United States
3 h-index
10 publications
1K citations
1–8 of 311
Repository · 6 publications · 171 citations
6
h-index
JME · 6 publications · 227 citations
6
h-index
3 publications · 163 citations
3
h-index
IJCP · 2 publications · 117 citations
2
h-index
2 publications · 104 citations
2
h-index
1–5